Skip Navigation


Human Molecular Genetics Advance Access first published online on November 25, 2008
This version published online on December 1, 2008

Human Molecular Genetics, doi:10.1093/hmg/ddn398
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Data
Right arrow All Versions of this Article:
18/4/688    most recent
ddn398v2
ddn398v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Garyali, P.
Right arrow Articles by Ganesh, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Garyali, P.
Right arrow Articles by Ganesh, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

The malin-laforin complex suppresses the cellular toxicity of misfolded proteins by promoting their degradation through the ubiquitin-proteasome system

Punitee Garyali#, Pratibha Siwach#, Pankaj Kumar Singh, Rajat Puri, Shuchi Mittal, Sonali Sengupta, Rashmi Parihar and Subramaniam Ganesh*

Department of Biological Sciences and Bioengineering, Indian Institute of Technology, Kanpur, India

* Corresponding author: Subramaniam Ganesh, Ph.D., Department of Biological Sciences and Bioengineering, Indian Institute of Technology, Kanpur 208016, India, Tel: +91-512-259-4040, Fax: +91-512-259-4010, Email: sganesh{at}iitk.ac.in

Received August 16, 2008; Revised November 12, 2008; Accepted November 19, 2008

Lafora disease (LD), a progressive form of inherited epilepsy, is associated with widespread neurodegeneration and the formation of polyglucosan bodies in the neurons. Laforin - a protein phosphatase, and malin - an E3 ubiquitin ligase, are two of the proteins that are defective in LD. We have shown recently that laforin and malin (referred together as LD proteins) are recruited to aggresome upon proteasomal blockade, possibly to clear misfolded proteins through the ubiquitin-proteasome system. Here we test this possibility using a variety of cytotoxic misfolded proteins, including the expanded polyglutamine protein, as potential substrates. Laforin and malin, together with Hsp70 as a functional complex, suppress the cellular toxicity of misfolded proteins, and all the three members of this complex are required for this function. Laforin and malin interact with misfolded proteins and promote their degradation through the ubiquitin-proteasome system. LD proteins are recruited to the polyglutamine aggregates and reduce the frequency of aggregate-positive cells. Taken together, our results suggest that the malin-laforin complex is a novel player in the neuronal response to misfolded proteins and could be potential therapeutic targets for neurodegenerative disorders associated with cytotoxic proteins.


# The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
R. Puri, T. Suzuki, K. Yamakawa, and S. Ganesh
Hyperphosphorylation and Aggregation of Tau in Laforin-deficient Mice, an Animal Model for Lafora Disease
J. Biol. Chem., August 21, 2009; 284(34): 22657 - 22663.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
Y. Liu, Y. Wang, C. Wu, Y. Liu, and P. Zheng
Deletions and missense mutations of EPM2A exacerbate unfolded protein response and apoptosis of neuronal cells induced by endoplasm reticulum stress
Hum. Mol. Genet., July 15, 2009; 18(14): 2622 - 2631.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.